Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1

Dominic A. Fitzgerald*, Michael Doumit, Francois Abel

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1'. Together they form a unique fingerprint.

Medicine & Life Sciences